241 related articles for article (PubMed ID: 19506528)
1. The lactotripeptides isoleucine-proline-proline and valine-proline-proline do not inhibit the N-terminal or C-terminal angiotensin converting enzyme active sites in humans.
Wuerzner G; Peyrard S; Blanchard A; Lalanne F; Azizi M
J Hypertens; 2009 Jul; 27(7):1404-9. PubMed ID: 19506528
[TBL] [Abstract][Full Text] [Related]
2. Lactopeptides and human blood pressure.
Geleijnse JM; Engberink MF
Curr Opin Lipidol; 2010 Feb; 21(1):58-63. PubMed ID: 19884823
[TBL] [Abstract][Full Text] [Related]
3. RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.
Junot C; Gonzales MF; Ezan E; Cotton J; Vazeux G; Michaud A; Azizi M; Vassiliou S; Yiotakis A; Corvol P; Dive V
J Pharmacol Exp Ther; 2001 May; 297(2):606-11. PubMed ID: 11303049
[TBL] [Abstract][Full Text] [Related]
4. Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme.
Pina AS; Roque AC
J Mol Recognit; 2009; 22(2):162-8. PubMed ID: 18816584
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline.
Azizi M; Junot C; Ezan E; Ménard J
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1066-9. PubMed ID: 11903317
[TBL] [Abstract][Full Text] [Related]
6. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats.
Sipola M; Finckenberg P; Santisteban J; Korpela R; Vapaatalo H; Nurminen ML
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 2):745-54. PubMed ID: 11785770
[TBL] [Abstract][Full Text] [Related]
7. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin-converting enzyme inhibition on plasma, urine, and tissue concentrations of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro in rats.
Junot C; Nicolet L; Ezan E; Gonzales MF; Menard J; Azizi M
J Pharmacol Exp Ther; 1999 Dec; 291(3):982-7. PubMed ID: 10565814
[TBL] [Abstract][Full Text] [Related]
9. Study of the mechanism of antihypertensive peptides VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis.
Yamaguchi N; Kawaguchi K; Yamamoto N
Eur J Pharmacol; 2009 Oct; 620(1-3):71-7. PubMed ID: 19686729
[TBL] [Abstract][Full Text] [Related]
10. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
[TBL] [Abstract][Full Text] [Related]
11. Myelopoiesis modulation by ACE hyperfunction in kinin B(1) receptor knockout mice: relationship with AcSDKP levels.
Oliveira CR; Paredes-Gamero EJ; Barbosa CM; Nascimento FD; Batista EC; Reis FC; Martins AH; Ferreira AT; Carmona AK; Pesquero JB; Tersariol IL; Araújo RC; Bincoletto C
Chem Biol Interact; 2010 Mar; 184(3):388-95. PubMed ID: 20096676
[TBL] [Abstract][Full Text] [Related]
12. Human in vivo study of the renin-angiotensin-aldosterone system and the sympathetic activity after 8 weeks daily intake of fermented milk.
Usinger L; Ibsen H; Linneberg A; Azizi M; Flambard B; Jensen LT
Clin Physiol Funct Imaging; 2010 Mar; 30(2):162-8. PubMed ID: 20113315
[TBL] [Abstract][Full Text] [Related]
13. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme.
Hirota T; Ohki K; Kawagishi R; Kajimoto Y; Mizuno S; Nakamura Y; Kitakaze M
Hypertens Res; 2007 Jun; 30(6):489-96. PubMed ID: 17664851
[TBL] [Abstract][Full Text] [Related]
14. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates.
Shalaby SM; Zakora M; Otte J
J Dairy Res; 2006 May; 73(2):178-86. PubMed ID: 16476177
[TBL] [Abstract][Full Text] [Related]
15. Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial.
Engberink MF; Schouten EG; Kok FJ; van Mierlo LA; Brouwer IA; Geleijnse JM
Hypertension; 2008 Feb; 51(2):399-405. PubMed ID: 18086944
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat in healthy cats.
Desmoulins PO; Burgaud S; Horspool LJ
J Vet Pharmacol Ther; 2008 Aug; 31(4):349-58. PubMed ID: 18638296
[TBL] [Abstract][Full Text] [Related]
17. Effects of milk casein derived tripeptides on endothelial enzymes in vitro; a study with synthetic tripeptides.
Siltari A; Kivimäki AS; Ehlers PI; Korpela R; Vapaatalo H
Arzneimittelforschung; 2012 Oct; 62(10):477-81. PubMed ID: 22918858
[TBL] [Abstract][Full Text] [Related]
18. Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits.
Chen X; Pitt BR; Moalli R; Gillis CN
J Pharmacol Exp Ther; 1984 Jun; 229(3):649-53. PubMed ID: 6327968
[TBL] [Abstract][Full Text] [Related]
19. High blood pressure-lowering and vasoprotective effects of milk products in experimental hypertension.
Ehlers PI; Kivimäki AS; Turpeinen AM; Korpela R; Vapaatalo H
Br J Nutr; 2011 Nov; 106(9):1353-63. PubMed ID: 21736845
[TBL] [Abstract][Full Text] [Related]
20. Renal and metabolic clearance of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) during angiotensin-converting enzyme inhibition in humans.
Azizi M; Ezan E; Reny JL; Wdzieczak-Bakala J; Gerineau V; Ménard J
Hypertension; 1999 Mar; 33(3):879-86. PubMed ID: 10082503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
